BIOVF - Swedish Orphan Biovitrum AB GAAP EPS of SEK 1.52 revenue of SEK 4B
- Swedish Orphan Biovitrum AB press release ( OTCPK:BIOVF ): Q3 GAAP EPS of SEK 1.52.
- Revenue of SEK 4B (+6.4% Y/Y).
- EBITA of SEK 1,241M; EBITA margin of 31%.
- EBIT of SEK 699M.
- Cash flow from operating activities SEK 780M.
- 2022 outlook unchanged.
For further details see:
Swedish Orphan Biovitrum AB GAAP EPS of SEK 1.52, revenue of SEK 4B